The infusion pump market is expected to grow by 5% through 2025, according to a new report from Future Market Insights.

The primary demand relates to more chronic pain, gastrointestinal disorders, cancer and diabetes, the firm said. Other factors include an increase in the senior populations and more availability of wireless technology.

However, a hampering growth factor relates to product recalls, including both voluntary recalls and recalls due to FDA mandates. The report segments the pumps into syringe, ambulatory, volumetric (peristaltic and piston-based), implantable, insulin, enteral, patient-controlled analgesic infusion pumps and pump accessories.

Companies discussed in the report include CareFusion Corporation, Medtronic Plc.,Smiths Medical, Johnson & Johnson Private Ltd., and Pfizer (Hospira) Inc.

To purchase the report, click here